Sclerosing mesenteritis (SM) can present alongside other gastrointestinal conditions and is associated with mild pain. First-line management addresses both the primary condition and any concurrent digestive disorders that may contribute to symptom burden.
Patients with SM may have co-existing gastrointestinal disorders — such as constipation, gastroesophageal reflux disease, or irritable bowel syndrome — that require concurrent management as part of the overall treatment approach.
Management begins with general supportive measures, including treating any co-existing gastrointestinal conditions present. For the mild pain associated with SM, a specific pharmacological class is used — the complete regimen, indications, and sequencing are detailed in the full protocol.
DOI: 10.1016/j.cgh.2024.12.025